Marker Therapeutics, Inc. MRKR Q2 2026 earnings

FAQ

When did Marker Therapeutics, Inc. report Q2 2026 earnings?

Marker Therapeutics, Inc. (MRKR) reported Q2 2026 earnings on August 14, 2026 before market open.

What were Marker Therapeutics, Inc.'s Q2 2026 revenue and EPS?

Marker Therapeutics, Inc. reported eps of $-0.09 for Q2 2026.

Did Marker Therapeutics, Inc. beat estimates in Q2 2026?

EPS beat the consensus estimate of $-0.25 by $0.16.

How did Marker Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 69.0% from $-0.29.

Where can I find Marker Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001104659-26-097262) directly on SEC EDGAR. The filing index links above go to sec.gov.